ROVI PHARMA INDUSTRIAL SERVICES, S.A. SAN SEBASTIAN DE LOS REYES
Date updated: 2025-04-07
TOTAL CONDITIONAL REGISTRATION: 1
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Related Articles
![[Interview] Navigating the OEM Health Supplement Journey: Lessons and Experiences Shared by Independent Pharmacies](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Ffv82li5l%2Fproduction%2F2458fe126fd64e9c0893e8d876348c0ab0c14340-1200x630.png%3Fw%3D400%26h%3D250%26fit%3Dmax%26auto%3Dformat&w=3840&q=75)
[Interview] Navigating the OEM Health Supplement Journey: Lessons and Experiences Shared by Independent Pharmacies
Manfye Goh · 13 min read
Telepharmacy in Malaysia: Advantages and Barriers
Dinesh Kumar · 5 min read
The Future of Community Pharmacy: A Shift from Products to Patients Centric Care
Manfye Goh · 11 min read
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| Spikevax 0.20 mg/mL dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) | MAL21086001ACZ | BIOLOGICS | ZUELLIG PHARMA SDN BHD | ROVI PHARMA INDUSTRIAL SERVICES, S.A. SAN SEBASTIAN DE LOS REYES | ZUELLIG PHARMA SDN BHD | CONDITIONAL REGISTRATION |
Spikevax 0.20 mg/mL dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)
Product Reg. noMAL21086001ACZ
TypeBIOLOGICS
Product HolderZUELLIG PHARMA SDN BHD
ManufacturerROVI PHARMA INDUSTRIAL SERVICES, S.A. SAN SEBASTIAN DE LOS REYES
ImporterZUELLIG PHARMA SDN BHD
Registration StatusCONDITIONAL REGISTRATION
Rows per page:
1–1 of 1